[{"id":"c354bd79-6619-40c4-8e90-94c882a12503","acronym":"","url":"https://clinicaltrials.gov/study/NCT05958199","created_at":"2023-07-24T15:08:51.673Z","updated_at":"2024-07-02T16:35:06.173Z","phase":"Phase 1","brief_title":"A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7","source_id_and_acronym":"NCT05958199","lead_sponsor":"NextPoint Therapeutics, Inc.","biomarkers":" HHLA2","pipe":"","alterations":" ","tags":["HHLA2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e NPX267"],"overall_status":"Recruiting","enrollment":" Enrollment 131","initiation":"Initiation: 07/21/2023","start_date":" 07/21/2023","primary_txt":" Primary completion: 01/01/2026","primary_completion_date":" 01/01/2026","study_txt":" Completion: 01/01/2026","study_completion_date":" 01/01/2026","last_update_posted":"2024-05-03"}]